← Leaderboards
Howard N Hodis
University Of Southern California
$51,156,356
Attributed
$51,156,356
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$51,156,356 · 9
By mechanism
R01$41,761,934 · 6
U01$9,203,105 · 2
M01$191,317 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Caleb E Finch$20,916,232
- Qifa Zhou$17,547,788
- Lon S Schneider$40,841,066
- Gutierrez Segall$61,378
- Manbir Singh$3,465,673
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
- Peter O Kohler · Oregon Health And Science University$38,512,009
Research focus
AtherosclerosisPostmenopausePlacebosHormone TherapyEstrogensClinical TrialsHuman SubjectCardiovascular DiseasesWomanCarotid ArteriesEstradiolCardiovascular Disorder PreventionClinical ResearchMenopauseRandomized Controlled TrialsTissuesAge RelatedCarotid ArteryRandomizedHuman Therapy EvaluationIntervention TrialAffectDouble-Blind Placebo Controlled TrialBase
Grant awards (48)
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy$2,803,461
R01 · FY2023 · AG · contact PI
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy$2,769,143
R01 · FY2022 · AG · contact PI
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY$724,027
R01 · FY2022 · AG · contact PI
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy$2,837,871
R01 · FY2021 · AG · contact PI
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY$724,027
R01 · FY2021 · AG · contact PI
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy$2,705,412
R01 · FY2020 · AG · contact PI
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY$724,027
R01 · FY2020 · AG · contact PI
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy$2,779,674
R01 · FY2019 · AG · contact PI
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY$724,027
R01 · FY2019 · AG · contact PI
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY$724,027
R01 · FY2018 · AG · contact PI
Vitamin D Intervention and Atherosclerosis Progression in African American Women$372,743
R01 · FY2014 · HL · contact PI
Vitamin D Intervention and Atherosclerosis Progression in African American Women$358,919
R01 · FY2013 · HL · contact PI
Biologic Response of Menopausal Women to 17B-Estradiol$611,871
R01 · FY2012 · AG · contact PI
Vitamin D Intervention and Atherosclerosis Progression in African American Women$390,445
R01 · FY2012 · HL · contact PI
Biologic Response of Menopausal Women to 17B-Estradiol$2,173,159
R01 · FY2011 · AG · contact PI
Biologic Response of Menopausal Women to 17B-Estradiol$1,723,605
R01 · FY2010 · AG · contact PI
Biologic Response of Menopausal Women to 17B-Estradiol$1,992,514
R01 · FY2008 · AG · contact PI
Phytoestrogens and Progression of Atherosclerosis$675,141
U01 · FY2008 · AT · contact PI
Biologic Response of Menopausal Women to 17B-Estradiol$1,978,297
R01 · FY2007 · AG · contact PI
Phytoestrogens and Progression of Atherosclerosis$1,796,742
U01 · FY2007 · AT · contact PI
Phytoestrogens and Progression of Atherosclerosis$1,896,837
U01 · FY2006 · AT · contact PI
Biologic Response of Menopausal Women to 17B-Estradiol$1,839,972
R01 · FY2006 · AG · contact PI
Biologic Response of Menopausal Women to 17B Estradiol$285,289
R01 · FY2006 · AG · contact PI
Phytoestrogens and Progression of Atherosclerosis$1,800,821
U01 · FY2005 · AT
Biologic Response of Menopausal Women to 17B-Estradiol$1,697,447
R01 · FY2005 · AG
PHYTOESTROGENS AND PROGRESSION OF ATHEROSCLEROSIS$159,018
U01 · FY2005 · AT
Phytoestrogens and Progression of Atherosclerosis$48,727
U01 · FY2005 · AT
Biologic Response of Menopausal Women to 17B-Estradiol$1,532,483
R01 · FY2004 · AG
Phytoestrogens and Progression of Atherosclerosis$1,100,948
U01 · FY2004 · AT
B VITAMIN ATHEROSCLEROSIS INTERVENTION TRAIL$923,023
R01 · FY2004 · AG
Phytoestrogens and Progression of Atherosclerosis$347,978
U01 · FY2004 · AT
Phytoestrogens/Progression of Atherosclerosis SUPPLEMENT$235,677
U01 · FY2004 · AT
ESTROGEN IN THE PREVENTION OF ATHEROSCLEROSIS TRIAL$228,685
R01 · FY2004 · AG
B VITAMIN ATHEROSCLEROSIS INTERVENTION TRAIL$1,573,243
R01 · FY2003 · AG
Phytoestrogens and Progression of Atherosclerosis$1,108,916
U01 · FY2003 · AT
ESTROGEN IN THE PREVENTION OF ATHEROSCLEROSIS TRIAL$235,983
R01 · FY2003 · AG
B VITAMIN ATHEROSCLEROSIS INTERVENTION TRAIL$1,694,716
R01 · FY2002 · AG
ESTROGEN IN THE PREVENTION OF ATHEROSCLEROSIS TRIAL$454,157
R01 · FY2002 · AG
TROGLITAZONE ATHEROSCLEROSIS REGRESSION TRIAL$0
M01 · FY2002 · RR
B VITAMIN ATHEROSCLEROSIS INTERVENTION TRAIL$1,950,407
R01 · FY2001 · AG
ESTROGEN IN THE PREVENTION OF ATHEROSCLEROSIS TRIAL$460,377
R01 · FY2001 · AG
TROGLITAZONE ATHEROSCLEROSIS REGRESSION TRIAL$155,764
M01 · FY2001 · RR
SUPPLEMENT B-Vitamin Atherosclerosis Intervention Trial$81,250
R01 · FY2001 · AG
CORONARY ANGIOGRAPHIC TRIAL OF ESTROGEN THERAPY$32,300
U01 · FY2001 · HL
TROGLITAZONE ATHEROSCLEROSIS REGRESSION TRIAL$0
M01 · FY2001 · RR
B VITAMIN ATHEROSCLEROSIS INTERVENTION TRAIL$1,687,653
R01 · FY2000 · AG
TROGLITAZONE ATHEROSCLEROSIS REGRESSION TRIAL$35,553
M01 · FY2000 · RR
TROGLITAZONE ATHEROSCLEROSIS REGRESSION TRIAL$0
M01 · FY2000 · RR